Back

Cervix Tumour Biomarker Test, PD-L1

Alternative Names/Synonyms	Solid Tumour Biomarker Testing, PD-L1
Laboratory	Anatomical Pathology
Sub-section	Surgical Pathology

Ordering Instructions, Requisition

Pathology Consultation and Biomarker Requisition

Clinical Significance

Reflex testing on cases of adult patients with persistent, recurrent, or metastatic cervical cancer when treatment is being considered. Biomarker: PD-L1 (CPS≥1)

Specimen Requirements (Sample Type)

Formalin fixed paraffin embedded block or tissue sections cut at 4 microns mounted on "Superfrost Plus" charged slides.

Cause for Rejection

Specimen Acceptability and Transport Guidance

Instrument, Methodology

Dako Omnis

Test Availability

Monday to Friday; 8 am to 5 pm

Reference Ranges

Please refer directly to the Pathology Report

Laboratory Contact Information

Tel: (416) 586-4800 extension 4457
Fax: (416) 586-8628
Email: PLMconsults@sinaihealth.ca

References

https://www.cancercareontario.ca/en/guidelines-advice/treatment-modality/pathology-laboratory-testing/genetic-testing-resources